Cancer pain: Beneficial effect of ketamine addition to a morphine-clonidine-lidocaine mixture administered by intrathecal route;DOULEURS CANCEREUSES: EFFET BENEFIQUE DE L'ADJONCTION DE KETAMINE AU MELANGE MORPHINE-CLONIDINE-LIDOCAINE ADMINISTRE PAR VOIE INTRATHECALE

Annales Francaises d'Anesthesie et de Reanimation

Volumn 15, Issue 3, 1996, Pages 271-276

  Muller, A ^a   Lemos, D ^a  

^a HÔPITAL CIVIL   (France)

Author keywords

cancer pain; clonidine; hyperalgesia; intrathecal administration; ketamine; morphine

Indexed keywords

CLONIDINE; KETAMINE; LIDOCAINE; MORPHINE; ANALGESIC AGENT;

ADULT; AGED; ARTICLE; CANCER PAIN; CASE REPORT; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; DRUG COMBINATION; INDWELLING CATHETER; INFUSION PUMP; INTRASPINAL DRUG ADMINISTRATION; MIDDLE AGED; NEOPLASM; PAIN;

AGED; ANALGESICS; CATHETERS, INDWELLING; CLONIDINE; DRUG COMBINATIONS; DRUG SYNERGISM; FEMALE; HUMANS; INFUSION PUMPS; INJECTIONS, SPINAL; KETAMINE; LIDOCAINE; MALE; MIDDLE AGED; MORPHINE; NEOPLASMS; PAIN;

EID: 0029948587     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0750-7658(96)80005-0     Document Type: Article

References (44)

1. Portenoy RK. Opioid tolerance and responsiveness: research findings and clinical observations. In: Gebhart JF, Hammond DL, Jensen TS, eds. Progress in pain research and management. Vol 2. Seattle: IASP Press, 1994:595-619
2. Yaksh T, Onofrio BM, High doses of spinal morphine produce a non-opiate receptor-mediated hyperesthesia: clinical and theoric implications. Anesthesioloy 1986;64:590-7
3. Mao J, Price DD, Mayer DJ. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 1995;62:259-74
4. Coombs DW, Saunders RL, Lachange D, Sasage S, Regnarsson TS, Jensen LE. Intrathecal morphine tolerance: use of intrathecal clonidine, DADLE, and intraventricular morphine. Anesthesiology 1985;62:358-63
5. Van Dongen RTM, Crul BJP, De Bock M. Long-term intrathecal infusion of morphine and morphine/bupivacaine mixture in the treatment of cancer pain: a retrospective analysis of 51 cases. Pain 1993;55:119-23
6. Sjöberg MD, Nitescu P, Appelgren L, Curelaru I. Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain. Anesthesiology 1994;84:284-97
7. De Castro J, Meynadier J, Zenz M. Regional opioid analgesia. Dordrecht: Kluwer Academic Publishers, 1991
8. Arner S, Meyerson B. Opioids in neuropathic pain. Pain Digest 1993;3:15-22
9. Muller A, Sudbrack G. Long-term spinal morphine: complications, failures, and pitfalls. In: Mumenthaler M, Van Zwieten PA, Farcot JM, eds. Treatment of chronic pain: possibilities, limitations and long-term follow-up. Chur: Harwood Academic Publishers, 1990:298-308
10. Krames ES. The chronic intraspinal use of opioid and local anesthetic mixture for the relief of intractable pain: when all else fails [editorial]. Pain 1993;55:1-4
11. Solomon RE, Gebhart GF. Synergistic antinociceptive interactions among drugs administered to the spinal cord. Anesth Analg 1994;78:1164-72
12. Gaumann DM, Brunet P, Jirounek P. Clonidine enhances the effects of lidocaine on C-fiber action potential. Anesth Analg 1992;74:719-25
13. Gurtu S, Shuka S, Mukerjee D. Morphine, clonidine coadministration in subanalgesic doses: effective control of tonic pain. Neuroreport 1994;5:715-7
14. Luo L, Puke M.JC, Wiesenfeld-Hallin Z. The effects of intrathecal morphine and clonidine on the prevention and reversal of spinal cord hyperexcitability following sciatic nerve section in the rat. Pain 1994;58:245-52
15. Mao J, Price DA, Mayer DJ, Hayes RL. Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy. Brain Res 1992;576:254-62
16. Lee YW, Yaksh TL. Analysis of drug interaction between intrathecal clonidine and MK-801 in peripheral neuropathic pain model. Anesthesiology 1995;82:741-8
17. Coderre TJ, Katz J, Vaccarino L, Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 1993;52:259-85
18. Stein C. The control of pain in peripheral tissue by opiods. N Engl J Med 1995;332:1685-90
19. e éd. Paris : Masson. À paraître
20. Inturrisi CE. NMDA receptors, nitric oxide and opioid tolerance. Regul Pept 1994;54:129-30
21. Nestler EJ, Hope BJ, Widnell KL. Drug addiction: a model for the molecular basis of neural plasticity. Neuron 1993;11:995-1006
22. Sosnowski M, Yaksh TL. Role of spinal adenosine receptors in modulating the hyperesthesia produced by spinal glycine receptor antagonism. Anesth Analg 1989;69:587-92
23. Seltzer Z, Cohn S, Ginzburg R, Belin B. Modulation of neuropathic pain behavior in rats by spinal desinhibition and NMDA receptor blockade of injury discharge. Pain 1991;45:69-75
24. Kristensen JD, Svensson B, Gordh T. The NMDA-receptor antagonist CPP abolishes neurogenic « wind-up pain » after intrathecal administration in humans. Pain 1992;51:249-53
25. Yamamoto T, Shimoyama N, Asano H, Mizuguchi T. Time-dependent effect of morphine and time-independent effect of MK-801, an NMDA antagonist, on the thermal hyperesthesia induced by unilateral constriction injury to the sciatic nerve in the rat. Anesthesiology 1994;80:1311-9
26. Eisenberg E, Vos BP, Strassmann AM. The NMDA antagonist memantine blocks pain behaviour in a rat model formalin-induced facial pain. Pain 1993;54:301-7
27. Yamamoto T, Shimoyama N, Mizuguchi T. The effect of morphine, MK-801, an NMDA antagonist, and CP-96.345, an NK1 antagonist, on the hyperesthesia evoked by carageenan injection in the rat paw. Anesthesiology 1993;78:124-33
28. Shukla VK, Lemaire S. Non-opioid effects of dynorphins: possible role of the NMDA receptor. TIPS 1994;15:420-4
29. Elliott K, Minami N, Kolesnikov YA, Pasternak GW, Inturrisi CE. The NMDA receptor antagonists, LY 274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine, but not to kappa opioids. Pain 1994;56:69-75
30. Yukhananov RY, Larson AA. Morphine modulates amino-acid-induced activity in the mouse spinal cord: short-term effects on NMDA and long-term effects on kainic acid. Brain Research 1994;646:194-200
31. Lipton SA. Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide. TINS 1993;16:527-32
32. Brockmeyer DM, Kendig JJ. Selective effects of ketamine on amino acid-mediated pathways in neonatal rat spinal cord. Br J Anaesth 1995;74:79-84
33. Gonzales JM, Loeb AL, Reichard PS, Irvine S. Ketamine inhibits glutamate-, NMDA-, and quisqualate-stimulated cGMP production in cultured cerebral neurons. Anesthesiology 1995;82:205-13
34. Nagasaka H, Nagasaka I, Sato I, Matsumoto N, Matsumoto I, Hori I. The effects of ketamine on the excitation and inhibition of dorsal horn WDR neuronal activity induced by bradykinin injection into the femoral artery in cats after spinal cord transection. Anesthesiology 1993;78:722-32
35. Arendt-Nielsen L, Petersen-Felix S, Bak P, Bjerring P, Zbinden AM. The effect of NMDA antagonist (ketamine) on a single and repeated nociceptive stimuli: a placebo-controlled experimental study. Anesth Analg 1995;81:63-8
36. Roytblat L, Korotkoruchko A, Katz J, Glazer M, Greemberg L, Fisher A. Postoperative pain: the effect of low-dose ketamine in addition to general anesthesia. Anesth Analg 1993;77:1161-5
37. Eide PK, Stubhaug A, Øye I, Breivik H. Continuous subcutaneous administration of the NMDA receptor antagonist ketamine in the treatment of post-herpectic neuralgia. Pain 1995;61:221-8
38. Persson J, Alexsson G, Hallin RG, Gustafsson L. Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization. Pain 1995;60:217-22
39. Backonja M, Arndt G, Gombar KA, Check B, Zimmermann M. Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain 1994;56:51-7
40. Knox DJ, MC Leod B.J, Goucke CR. Acute phantom limb pain controlled by ketamine. Anaesth Intensive Care 1995;23:620-2
41. Ogawa S, Kanamura T, Noda K, Saeki S, Katsumata N, Kato J et al. Intravenous microdrip infusion of ketamine in subanaesthetic doses for intractable terminal cancer pain. Pain Clinic 1994;7:125-9
42. Cherry DA, Plummer JL, Gourlay K, Coates KR, Odgers CL. Ketamine as an adjunct to morphine in the treatment of pain. Pain 1995;62:119-21
43. Chu YH, Wong CS, Ho ST, Watkins WD. Epidural coadministration of ketamine and morphine attenuates the neuropathic pain: a case report. Pain Clinic 1995;8:236-7
44. Borgbjerg FM, S vensson BA, Frigast C, Gordh T. Histopathology after repeated intrathecal injections of preservative-free ketamine in the rabbit: a light and electron microscopic examination. Anesth Analg 1994;79:105-11